Profit Margin (Quarterly) Chart

View Profit Margin (Quarterly) for ZBH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Profit Margin (Quarterly) Chart
Start Trial

Historical Profit Margin (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
June 30, 2026 9.17%
March 31, 2026 11.42%
December 31, 2025 6.15%
September 30, 2025 11.55%
June 30, 2025 7.38%
March 31, 2025 9.56%
December 31, 2024 11.86%
September 30, 2024 13.66%
June 30, 2024 12.52%
March 31, 2024 9.15%
December 31, 2023 21.63%
September 30, 2023 9.28%
June 30, 2023 11.23%
March 31, 2023 12.71%
December 31, 2022 -7.13%
September 30, 2022 11.63%
June 30, 2022 8.64%
March 31, 2022 4.40%
December 31, 2021 -3.08%
September 30, 2021 9.64%
June 30, 2021 8.21%
March 31, 2021 12.05%
December 31, 2020 16.01%
September 30, 2020 12.76%
June 30, 2020 -16.98%
Date Value
March 31, 2020 -28.54%
December 31, 2019 15.12%
September 30, 2019 22.83%
June 30, 2019 6.63%
March 31, 2019 12.46%
December 31, 2018 -43.58%
September 30, 2018 8.83%
June 30, 2018 9.21%
March 31, 2018 8.73%
December 31, 2017 59.53%
September 30, 2017 5.43%
June 30, 2017 9.44%
March 31, 2017 15.17%
December 31, 2016 3.31%
September 30, 2016 8.62%
June 30, 2016 -1.64%
March 31, 2016 5.71%
December 31, 2015 6.55%
September 30, 2015 1.26%
June 30, 2015 -13.55%
March 31, 2015 15.59%
December 31, 2014 12.80%
September 30, 2014 14.95%
June 30, 2014 14.89%
March 31, 2014 19.04%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Intuitive Surgical, Inc. 28.46%
Stryker Corp. 19.37%
Globus Medical, Inc. 19.20%
Solventum Corp. 4.16%
Boston Scientific Corp. 16.63%